Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections
Launched by CAIRO UNIVERSITY · May 27, 2024
Trial Information
Current as of March 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age \> 18 years.
- • 2. American society of anesthesiology (ASA) class II (Normal pregnancy, well controlled gestational HTN, controlled preeclampsia without severe features, diet-controlled gestational DM).
- • 3. Singleton term pregnancy.
- • 4. Elective caesarean section.
- • 5. Spinal anesthesia.
- Exclusion Criteria:
- • 1. Atypical postoperative care e.g. following caesarean hysterectomy.
- • 2. Inflammatory bowel disease.
- • 3. Prolonged surgery \>1.5 hours.
- • 4. Medical disorders e.g. liver or renal affection
- • 5. Previous bowel surgery.
- • 6. History' of allergic reaction to lidocaine.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
